Although cancer treatment has improved dramatically over recent decades, it continues to
remain among the most challenging public health issues. Comprehensive cancer …

Recent years have witnessed dramatic improvements in nanotechnology-based cancer
therapeutics, and it continues to evolve from the use of conventional therapies …

Cancer remains a great threat to humans and its treatments are limited to chemotherapy,
surgery, and radiotherapy. Such treatment strategies cannot be considered clinically safe …

Cancer treatment has yet to find a “silver bullet” capable of selectively and effectively kill
tumor cells without damaging healthy cells. Nanomedicine is a promising field that can …

The majority of nanomedicines in (pre) clinical trials are based on established drugs, such
as doxorubicin and paclitaxel. Does that make sense? To some extent yes, because a lot of …

Malignant tumors remain a major health burden throughout the world and effective
therapeutic strategies are urgently needed. Cancer nanotechnology, as an integrated …

Cancer has become one of the primary threats to human beings, and traditional therapies
(including surgery, chemotherapy and radiotherapy) show limited therapeutic efficacy due to …

Anticancer nanomedicines have been studied over 30 years, but fewer than 10 formulations
have been approved for clinical therapy today. Despite abundant options of anticancer …

Recent developments in nanotechnology have brought new approaches to cancer
diagnosis and therapy. While enhanced permeability and retention effect promotes nano …

Cancer is an outrageous disease with uncontrolled differentiation, growth, and migration to
the other parts of the body. It is the second-most common cause of death both in the US and …